Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Todos Medical Ltd (TOMDF)
Todos Medical Ltd (TOMDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 477
  • Shares Outstanding, K 1,193,175
  • Annual Sales, $ 12,230 K
  • Annual Income, $ -43,310 K
  • 60-Month Beta N/A
  • Price/Sales 0.04
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade TOMDF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 12/12/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0003 +33.33%
on 12/08/23
0.0005 -20.00%
on 12/07/23
-0.0001 (-20.00%)
since 11/08/23
3-Month
0.0003 +33.33%
on 12/08/23
0.0006 -33.33%
on 10/25/23
-0.0002 (-33.33%)
since 09/08/23
52-Week
0.0003 +33.33%
on 12/08/23
0.0115 -96.52%
on 12/20/22
-0.0101 (-96.19%)
since 12/08/22

Most Recent Stories

More News
Todos Medical Completes Trial Design for Tollovid™ Long COVID Clinical Study in Adults

§  3-arm randomized, controlled study to evaluate 15-day and 30-day treatment regimens §  Finalizing contracts with two Long COVID clinics to recruit...

TOMDF : 0.0004 (unch)
Todos Medical Announces PCR Validation of Wound and Respiratory Pathogen Panels at CLIA/CAP Lab Provista Diagnostics

New York, NY, and Tel Aviv, ISRAEL , Aug. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive...

TOMDF : 0.0004 (unch)
Todos Medical Announces First Two Contracts for PCR-based MonkeyPox Testing at CLIA/CAP Clinical Testing Laboratory Provista Diagnostics

New York, NY, and Tel Aviv, ISRAEL, Aug. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...

TOMDF : 0.0004 (unch)
Todos Medical Announces First Long COVID Clinic Laboratory Services Agreement for Long COVID Panel Biomarker Partnership with Amerimmune Diagnostics

RTHM collaborating on Tollovid™ 3CL inhibitor immune support supplement case studies Tollovid biomarker data to support potential structure-function...

TOMDF : 0.0004 (unch)
Todos Medical Initiates Validation Plan for PCR-based MonkeyPox Test at CLIA/CAP Clinical Testing Laboratory Provista Diagnostics

§  Lesion swab (standard of care) and saliva-based sample collection planned §  Peer-reviewed publication demonstrating saliva testing sensitivity...

TOMDF : 0.0004 (unch)
Todos Medical Announces Preprint of Acute COVID-19 Paxlovid Rebound Rescued by Tollovid

New York, NY, and Tel Aviv, ISRAEL, Aug. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...

TOMDF : 0.0004 (unch)
Todos Medical Partners with Amerimmune Diagnostics on Long COVID Biomarker Panel

NEW YORK, NY, AND TEL AVIV, ISRAEL, July 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...

TOMDF : 0.0004 (unch)
Todos Medical Reports Case Study #7 in Acute and Long COVID

New York, NY, and Tel Aviv, ISRAEL, July 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...

TOMDF : 0.0004 (unch)
Todos Medical Announces Positive Biomarker Data from Phase 2 Trial of Tollovir in Hospitalized COVID-19 Patients

§  Biomarker data correlates with clinical data announced in January 2022 §  46 patient open label extension being opened to support US FDA EUA...

TOMDF : 0.0004 (unch)
Todos Medical Releases Preliminary Data From IRB-Waived Tollovid® Market Research Study in Acute and Long COVID

83% of Respondents With Acute COVID Were Satisfied 68% of Respondents With Long COVID Were Satisfied NEW YORK, NY, and TEL AVIV, ISRAEL, June 23,...

TOMDF : 0.0004 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0005
2nd Resistance Point 0.0005
1st Resistance Point 0.0004
Last Price 0.0004
1st Support Level 0.0003
2nd Support Level 0.0003
3rd Support Level 0.0002

See More

52-Week High 0.0115
Fibonacci 61.8% 0.0072
Fibonacci 50% 0.0059
Fibonacci 38.2% 0.0046
Last Price 0.0004
52-Week Low 0.0003

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar